Neurofibromatosis provisions, as follows:
Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division A - Department of Defense Appropriations Act, FY2024
Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division D - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024
Department of Defense Appropriations Act, FY2025
Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025
Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division A - Department of Defense Appropriations Act, FY2024, Neurofibromatosis provisions
Department of Defense Appropriations Act, FY2025, Neurofibromatosis provisions
Duration: January 8, 2009
to
present
General Issues: Budget/Appropriations , Defense
Spending: about $240,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2009: House of Representatives, U.S. Senate, Defense - Dept of (DOD), Natl Institutes of Health (NIH), Defense - Dept of (DOD), Defense - Dept of (DOD),, U.S. Senate,
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Edward Long PhD Legislative Assistant, Senator Tom Harkin
Edward Long (COP cont.) PhD Legislative Director, Senator Brock Adams
Legislative Director, Senator Tom Harkin
StaffDir, Sen Subcomm on Labor, HHS, Education Approps
Katherine Vanlandingham Legislative Asst/Correspondence Dir, Senator Sam Brownback
LegAsst/CorrespDir, Senator Sam Brownback
Edward Long, PhD Legislative Assistant, Senator Tom Harkin
Edward Long, PhD (COP cont.) Legislative Director, Senator Brock Adams
Legislative Director, Senator Tom Harkin
StaffDir,SenSubcommOnLabor,HHS,Ed Approps
Brian Robinson SrLA/Cnsel,Congresswoman Millender-McDonald
Brian Robinson (COP cont.) LA/Corr,Congresswoman Sheila Jackson Lee
H. Stewart Van Scoyoc n/a
Laurie Katz n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on April 19.
Original Filing: 301564538.xml
Lobbying Issues
Neurofibromatosis provisions, as follows:
Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division A - Department of Defense Appropriations Act, FY2024
Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division D - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024
Department of Defense Appropriations Act, FY2025
Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2025
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division A - Department of Defense Appropriations Act, FY2024, Neurofibromatosis provisions
Department of Defense Appropriations Act, FY2025, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2023
In Q4, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on Jan. 19.
Original Filing: 301529528.xml
Lobbying Issues
Neurofibromatosis provisions, as follows:
H.R.4365/S.2587, Department of Defense Appropriations Act, FY2024
H.R.5894/S.2624, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.4365/S.2587, Department of Defense Appropriations Act, FY2024, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2023
In Q3, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on Oct. 19, 2023.
Original Filing: 301505779.xml
Lobbying Issues
Monitor Neurofibromatosis provisions, as follows:
H.R.4365/S.2587, Department of Defense Appropriations Act, FY2024
S.2624, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024
Lobbying Issues
H.R.4365/S.2587, Department of Defense Appropriations Act, FY2024, Neurofibromatosis provisions
2nd Quarter, 2023
In Q2, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on July 19, 2023.
Original Filing: 301481873.xml
Lobbying Issues
Neurofibromatosis provisions, as follows:
H.R.4365, Department of Defense Appropriations Act, FY2024
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.4365, Department of Defense Appropriations Act, FY2024, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2023
In Q1, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on April 19, 2023.
Original Filing: 301458528.xml
Lobbying Issues
Neurofibromatosis provisions, as follows:
Department of Defense Appropriations Act, FY2024
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations Act, FY2024, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2022
In Q4, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on Jan. 19, 2023.
Original Filing: 301432502.xml
Lobbying Issues
Monitor Neurofibromatosis provisions, as follows:
H.R.8236/S.4663, Department of Defense Appropriations Act, FY2023
H.R.8295/S.4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023
Public Law 117-328, Consolidated Appropriations Act, FY2023
Lobbying Issues
Monitor Neurofibromatosis provisions, as follows:
H.R.8236/S.4663, Department of Defense Appropriations Act, FY2023
Public Law 117-328, Consolidated Appropriations Act, FY2023
3rd Quarter, 2022
In Q3, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on Oct. 19, 2022.
Original Filing: 301410654.xml
Lobbying Issues
Neurofibromatosis provisions, as follows:
H.R.8236/S.4663, Department of Defense Appropriations Act, FY2023
Monitor H.R.8295/S.4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.8236/S.4663, Department of Defense Appropriations Act, FY2023, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2022
In Q2, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on July 19, 2022.
Original Filing: 301384931.xml
Lobbying Issues
Neurofibromatosis provisions, as follows:
H.R.8236, Department of Defense Appropriations Act, FY2023
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.8236, Department of Defense Appropriations Act, FY2023, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2022
In Q1, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on April 19, 2022.
Original Filing: 301363553.xml
Lobbying Issues
Neurofibromatosis provisions, as follows:
H.R.4432/S.3023, Department of Defense Appropriations Act, FY2022
H.R.4502/S.3062, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022
Public Law 117-103, Consolidated Appropriations Act, FY2022
Department of Defense Appropriations Act, FY2023
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2023
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Neurofibromatosis provisions, as follows:
H.R.4432/S.3023, Department of Defense Appropriations Act, FY2022
Department of Defense Appropriations Act, FY2023
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2021
In Q4, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on Jan. 19, 2022.
Original Filing: 301327616.xml
Lobbying Issues
Neurofibromatosis provisions, as follows:
H.R.4432/S.3023, Department of Defense Appropriations Act, FY2022
H.R.4502/S.3062, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.4432/S.3023, Department of Defense Appropriations Act, FY2022, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2021
In Q3, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on Oct. 19, 2021.
Original Filing: 301303035.xml
Lobbying Issues
Neurofibromatosis provisions, as follows:
H.R.4432, Department of Defense Appropriations Act, FY2022
H.R.4502, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.4432, Department of Defense Appropriations Act, FY2022, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2021
In Q2, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on July 19, 2021.
Original Filing: 301279943.xml
Lobbying Issues
Neurofibromatosis provisions, as follows:
Department of Defense Appropriations Act, FY2022
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations Act, FY2022, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2021
In Q1, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on April 19, 2021.
Original Filing: 301255781.xml
Lobbying Issues
Neurofibromatosis provisions, as follows:
Department of Defense Appropriations Act, FY2022
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations Act, FY2022, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2020
In Q4, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on Jan. 19, 2021.
Original Filing: 301234188.xml
Lobbying Issues
Provisions relating to NIH; and Neurofibromatosis provisions, as follows:
H.R.7617, Department of Defense Appropriations Act, FY2021
H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021
Public Law 116-260, Consolidated Appropriations Act, 2021, Division C, Department of Defense Appropriations Act, 2021, and Division H, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Neurofibromatosis provisions, as follows:
H.R.7617, Department of Defense Appropriations Act, FY2021
Public Law 116-260, Consolidated Appropriations Act, 2021, Division C, Department of Defense Appropriations Act, 2021
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2020
In Q3, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on Oct. 19, 2020.
Original Filing: 301214212.xml
Lobbying Issues
Provisions relating to NIH; and Neurofibromatosis provisions, as follows:
H.R.7617, Department of Defense Appropriations Act, FY2021
H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021
H.R.8319, Continuing Appropriations, FY2021 and Other Extensions Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.7617, Department of Defense Appropriations Act, FY2021, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2020
In Q2, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on July 17, 2020.
Original Filing: 301191924.xml
Lobbying Issues
Provisions relating to NIH; and Neurofibromatosis provisions, as follows:
Department of Defense Appropriations Act, FY2021
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations Act, FY2021, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2020
In Q1, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on April 17, 2020.
Original Filing: 301169118.xml
Lobbying Issues
Provisions relating to NIH; and Neurofibromatosis provisions, as follows:
Department of Defense Appropriations Act, FY2021
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021
Monitor Coronavirus, Healthcare and Non-Profit related issues
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations Act, FY2021, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2019
In Q4, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on Jan. 17, 2020.
Original Filing: 301108245.xml
Lobbying Issues
Provisions relating to NIH; and Neurofibromatosis provisions, as follows:
Public Law 116-93, Consolidated Appropriations Act, 2020, Division A -- Department of Defense Appropriations Act, FY2020
Public Law 116-94, Further Consolidated Appropriations Act, 2020, Division A -- Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2020
Public Law 116-59, Continuing Appropriations Act, 2020, and Health Extenders Act of 2019
Public Law 116-69, Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 116-93, Consolidated Appropriations Act, 2020, Division A -- Department of Defense Appropriations Act, FY2020, Provisions relating to NIH; and Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2019
In Q3, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on Oct. 18, 2019.
Original Filing: 301070038.xml
Lobbying Issues
Provisions relating to NIH; and Neurofibromatosis provisions, as follows:
H.R.2968S/S.2474, Department of Defense Appropriations, FY2020
H.R.2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2020
H. Res. 431 -- combined the following four regular appropriations bills, 2020, as reported: (1) Labor-HHS-Education (H.R. 2740), (2) Defense (H.R.2968), (3) State-Foreign Operations (H.R. 2839, as modified by the first rule), and (4) Energy and Water (H.R. 2960)
H.R.4378, Continuing Appropriations Act, 2020, and Health Extenders Act of 2019
Public Law 116-37, Bipartisan Budget Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Provisions relating to NIH; and Neurofibromatosis provisions, as follows:
H.R.2968S/S.2474, Department of Defense Appropriations, FY2020
H. Res. 431 -- combined the following four regular appropriations bills, 2020, as reported: (1) Labor-HHS-Education (H.R. 2740), (2) Defense (H.R.2968), (3) State-Foreign Operations (H.R. 2839, as modified by the first rule), and (4) Energy and Water (H.R. 2960)
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2019
In Q2, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on July 19, 2019.
Original Filing: 301050149.xml
Lobbying Issues
Provisions relating to NIH; and Neurofibromatosis provisions, as follows:
H.R.2968, Department of Defense Appropriations, FY2020
H.R.2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2020
H. Res. 431 -- combined the following four regular appropriations bills, 2020, as reported: (1) Labor-HHS-Education (H.R. 2740), (2) Defense (H.R.2968), (3) State-Foreign Operations (H.R. 2839, as modified by the first rule), and (4) Energy and Water (H.R. 2960)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Provisions relating to NIH; and Neurofibromatosis provisions, as follows:
H.R.2968, Department of Defense Appropriations, FY2020
H. Res. 431 -- combined the following four regular appropriations bills, 2020, as reported: (1) Labor-HHS-Education (H.R. 2740), (2) Defense (H.R.2968), (3) State-Foreign Operations (H.R. 2839, as modified by the first rule), and (4) Energy and Water (H.R. 2960)
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2019
In Q1, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on April 19, 2019.
Original Filing: 301030301.xml
Lobbying Issues
Provisions relating to NIH; and Neurofibromatosis provisions, as follows:
Department of Defense Appropriations, FY2020
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations, FY2020, Provisions relating to NIH; and Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2018
In Q4, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on Jan. 18, 2019.
Original Filing: 301009294.xml
Lobbying Issues
Public law 115-245, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Provisions relating to NIH; and Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget/Appropriations
3rd Quarter, 2018
In Q3, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on Oct. 19, 2018.
Original Filing: 300991978.xml
Lobbying Issues
H.R.6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Provisions relating to NIH; and Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Budget/Appropriations
2nd Quarter, 2018
In Q2, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on July 19, 2018.
Original Filing: 300969803.xml
Lobbying Issues
S.3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2019, provisions relating to NIH
H.R.6157/S.3159, Department of Defense Appropriations Act, FY2019, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.6157/S.3159, Department of Defense Appropriations Act, FY2019, Neurofibromatosis provisions
H.R.5515/S.2987, National Defense Authorization for Fiscal Year 2019, Monitor medical research issues
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2018
In Q1, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on April 19, 2018.
Original Filing: 300948388.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2019, provisions relating to NIH
Department of Defense Appropriations Act, FY2019, Neurofibromatosis provisions
Public Law 115-141, Consolidated Appropriations Act, FY2018, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations Act, FY2019, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2017
In Q4, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on Jan. 22, 2018.
Original Filing: 300932348.xml
Lobbying Issues
H.R.3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2018, provisions relating to NIH
H.R.3219, Defense, Military Construction, Veterans Affairs, Legislative Branch, and Energy and Water Development National Security Appropriations Act, FY2018, Make America Secure Appropriations Act, FY2018, Neurofibromatosis provisions
Public Law 115-56, Continuing Appropriations Act, FY2018 and Supplemental Appropriations for Disaster Relief Requirements Act, FY2017, Neurofibromatosis provisions
H.R.3354, Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018, Neurofibromatosis provisions
Public Law 115-90, Making further continuing appropriations for fiscal year 2018, and for other purposes, provisions relating to dietary supplements, Neurofibromatosis provisions
Public Law 115-96, Further Additional Continuing Appropriations Act, FY2018, provisions relating to dietary supplements, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Public Law 115-91, National Defense Authorization for Fiscal Year 2018, Medical research provisions
H.R.3219, Defense, Military Construction, Veterans Affairs, Legislative Branch, and Energy and Water Development National Security Appropriations Act, FY2018, Make America Secure Appropriations Act, FY2018, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2017
In Q3, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on Oct. 20, 2017.
Original Filing: 300911184.xml
Lobbying Issues
H.R.3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2018, provisions relating to NIH
H.R.3219, Defense, Military Construction, Veterans Affairs, Legislative Branch, and Energy and Water Development National Security Appropriations Act, FY2018, Make America Secure Appropriations Act, FY2018, Neurofibromatosis provisions
Public Law 115-56, Continuing Appropriations Act, FY2018 and Supplemental Appropriations for Disaster Relief Requirements Act, FY2017
H.R.3354, Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.2810/S.1519, National Defense Authorization for Fiscal Year 2018, Medical research provisions
H.R.3219, Defense, Military Construction, Veterans Affairs, Legislative Branch, and Energy and Water Development National Security Appropriations Act, FY2018, Make America Secure Appropriations Act, FY2018, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2017
In Q2, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on July 20, 2017.
Original Filing: 300891801.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2018, provisions relating to NIH
Department of Defense Appropriations, FY2018, Neurofibromatosis provisions
Public Law 114-254, Further Continuing and Security Assistance Appropriations Act, FY2017, Neurofibromatosis provisions
Public Law 115-30, Making further continuing appropriations for fiscal year 2017, and for other purposes
Public Law 115-31, Consolidated Appropriations Act, FY2017
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
National Defense Authorization for Fiscal Year 2018, Medical research provisions
Neurofibromatosis provisions, as follows:
Public Law 115-30, Making further continuing appropriations for fiscal year 2017, and for other purposes
Public Law 115-31, Consolidated Appropriations Act, FY2017
Department of Defense Appropriations Act, FY2018
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2017
In Q1, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on April 19, 2017.
Original Filing: 300871538.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017 and FY2018, provisions relating to NIH
H.R.1301, Department of Defense Appropriations, FY2017, Neurofibromatosis provisions
Department of Defense Appropriations, FY2018, Neurofibromatosis provisions
Public Law 114-254, Further Continuing and Security Assistance Appropriations Act, FY2017, Neurofibromatosis provisions
President Trump's 2018 Budget Blueprint
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.1301, Department of Defense Appropriations, FY2017, Neurofibromatosis provisions
Department of Defense Appropriations, FY2018, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2016
In Q4, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on Jan. 20, 2017.
Original Filing: 300852810.xml
Lobbying Issues
H.R.5926/S.3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, provisions relating to NIH
H.R.5293/S.3000, Department of Defense Appropriations, FY2017, Neurofibromatosis provisions
Public Law 114-223, Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2017, and Zika Response and Preparedness Act, Neurofibromatosis provisions
Public Law 114-254, Further Continuing and Security Assistance Appropriations Act, FY2017, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.5293/S.3000, Department of Defense Appropriations, FY2017, Neurofibromatosis provisions
H.R.4909/S.2943, National Defense Authorization Act for Fiscal Year 2017, Medical research provisions
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2016
In Q3, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on Oct. 19, 2016.
Original Filing: 300831513.xml
Lobbying Issues
H.R.5926/S.3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, provisions relating to NIH
H.R.5293/S.3000, Department of Defense Appropriations, FY2017, Neurofibromatosis provisions
H.R.5325, Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2017, and Zika Response and Preparedness Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.5293/S.3000, Department of Defense Appropriations, FY2017, Neurofibromatosis provisions
H.R.4909/S.2943, National Defense Authorization Act for Fiscal Year 2017, Medical research provisions
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2016
In Q2, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on July 19, 2016.
Original Filing: 300812794.xml
Lobbying Issues
S.3040, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, provisions relating to NIH
H.R.5293/S.3000, Department of Defense Appropriations, FY2017, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.5293/S.3000, Department of Defense Appropriations, FY2017, Neurofibromatosis provisions
S.2943, National Defense Authorization Act for Fiscal Year 2017, Medical research provisions
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2016
In Q1, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on April 19, 2016.
Original Filing: 300796544.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2017, provisions relating to NIH
Department of Defense Appropriations, FY2017, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Department of Defense Appropriations, FY2017, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2015
In Q4, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on Jan. 19, 2016.
Original Filing: 300774527.xml
Lobbying Issues
H.R.3020/S.1695, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2016, provisions relating to NIH
H.R.2685/S.1558, Department of Defense Appropriations, FY2016, Neurofibromatosis provisions
Public Law No: 114-53, Continuing Appropriations Act, FY2016, Neurofibromatosis provisions
H.R.2250, Further Continuing Appropriations Act, FY2016, Neurofibromatosis provisions
Public Law No. 114-113, Consolidated Appropriations Act, FY2016, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.2685/S.1558, Department of Defense Appropriations, FY2016, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2015
In Q3, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on Oct. 17, 2015.
Original Filing: 300755936.xml
Lobbying Issues
H.R.3020/S.1695, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2016, provisions relating to NIH
H.R.2685/S.1558, Department of Defense Appropriations, FY2016, Neurofibromatosis provisions
Public Law No: 114-53, Continuing Appropriations Act, FY2016, Neurofibromatosis provsisions
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.2685/S.1558, Department of Defense Appropriations, FY2016, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2015
In Q2, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on July 17, 2015.
Original Filing: 300737583.xml
Lobbying Issues
S.1695, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2016, provisions relating to NIH
H.R.2685/S.1558, Department of Defense Appropriations, FY2016, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R.1735/S.1558, National Defense Authorization Act for Fiscal Year 2015, Neurofibromatosis provisions
H.R.2685/S.1558, Department of Defense Appropriations, FY2016, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2015
In Q1, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest . The report was filed on April 17, 2015.
Original Filing: 300717922.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2016, provisions relating to NIH
Department of Defense Appropriations, FY2016, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2014
In Q4, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on Jan. 19, 2015.
Original Filing: 300700633.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2015, provisions relating to NIH
H.R.4870, Department of Defense Appropriations, FY2015, Neurofibromatosis provisions
Public Law 113-164, Continuing Appropriations Resolution, FY2015, Neurofibromatosis provisions
Public Law 113-235, Consolidated and Further Continuing Appropriations Act, FY2015, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2014
In Q3, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on Oct. 16, 2014.
Original Filing: 300677413.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2015, provisions relating to NIH
H.R.4870, Department of Defense Appropriations, FY2015, Neurofibromatosis provisions
Public Law 113-164, Continuing Appropriations Resolution, FY2015, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2014
In Q2, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on July 16, 2014.
Original Filing: 300657740.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2015, provisions relating to NIH
H.R.4870, Department of Defense Appropriations, FY2015, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2014
In Q1, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on April 18, 2014.
Original Filing: 300640548.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies
Appropriations, FY2015, provisions relating to NIH
Department of Defense Appropriations, FY2015, Neurofibromatosis provisions
Public Law 113-46, Continuing Appropriations Act, FY2014, generally
Public Law 113-73, Making further continuing appropriations for fiscal year 2014, and for other purposes, generally
Public Law 113-76, Consolidated Appropriations Act, FY2014, generally
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on Jan. 17, 2014.
Original Filing: 300617347.xml
Lobbying Issues
S.1284, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2014, provisions relating to NIH
H.R.2397/S.1429, Department of Defense Appropriations, FY2014, Neurofibromatosis provisions
H.J.Res.59, Continuing Appropriations Resolution, FY2014, generally
Public Law 113-46, Continuing Appropriations Act, FY2014, generally
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2013
In Q3, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on Oct. 19, 2013.
Original Filing: 300601110.xml
Lobbying Issues
S.1284, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2014, provisions relating to NIH
H.R.2397/S.1429, Department of Defense Appropriations, FY2014, Neurofibromatosis provisions
H.J.Res.59, Continuing Appropriations Resolution, FY2014, generally
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2013
In Q2, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on July 18, 2013.
Original Filing: 300574990.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2014, provisions relating to NIH
H.R.2397, Department of Defense Appropriations, FY2014, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
In Q1, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on April 20, 2013.
Original Filing: 300558113.xml
Lobbying Issues
S.3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2013, provisions relating to NIH
H.R.5856, Department of Defense Appropriations, FY2013, Neurofibromatosis provisions
Monitor Public Law 112-25, Budget Control Act of 2011, Neurofibromatosis provisions
Public Law 112-175, Continuing Appropriations Resolution, FY2013, Neurofibromatosis provisions
Public Law 113-6, Consolidated and Further Continuing Appropriations Act, FY2013, Neurofibromatosis provisions
Public Law 112-240, American Taxpayer Relief Act of 2012, Neurofibromatosis provisions
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2014, provisions relating to NIH
Department of Defense Appropriations, FY2014, Neurofibromatosis provisions
Monitor the following:
H.Con.Res.25,Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 (House Concurrent Resolution)
S.Con.Res.8, An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2014, revising the appropriate budgetary levels for fiscal year 2013, and setting forth the appropriate budgetary levels for fiscal years 2015 through 2023 (Senate Concurrent Resolution)
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2012
In Q4, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on Jan. 21, 2013.
Original Filing: 300536924.xml
Lobbying Issues
S.3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2013, provisions relating to NIH
H.R.5856, Department of Defense Appropriations, FY2013, Neurofibromatosis provisions
Monitor Public Law 112-25, Budget Control Act of 2011, Neurofibromatosis provisionsH.J.Res.117, Continuing Appropriations Resolution, FY2013, Neurofibromatosis provisions
H.R. 8, American Taxpayer Relief Act of 2012, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2012
In Q3, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on Oct. 17, 2012.
Original Filing: 300508156.xml
Lobbying Issues
S.3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2013, provisions relating to NIH
H.R.5856, Department of Defense Appropriations, FY2013, Neurofibromatosis provisions
Monitor Public Law 112-25, Budget Control Act of 2011, Neurofibromatosis provisionsH.J.Res.117, Continuing Appropriations Resolution, FY2013, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2012
In Q2, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on July 16, 2012.
Original Filing: 300484443.xml
Lobbying Issues
S.3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2013, provisions relating to NIH
H.R.5856, Department of Defense Appropriations, FY2013, Neurofibromatosis provisions
Monitor Public Law 112-25, Budget Control Act of 2011, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2012
In Q1, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on April 19, 2012.
Original Filing: 300465098.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2013, provisions relating to NIH
H.R.2219, Department of Defense Appropriations, FY2013, Neurofibromatosis provisions
Monitor Public Law 112-25, Budget Control Act of 2011, Neurofibromatosis provisions
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2011
In Q4, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on Jan. 19, 2012.
Original Filing: 300442115.xml
Lobbying Issues
S.1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2012, provisions relating to NIH
H.R.2219, Department of Defense Appropriations, FY2012, Disease specific program
Public Law 112-74, Consolidated Appropriations Act, FY2012, provisions relating to NIH; Disease specific programMonitor the following:
Public Law 112-33, Continuing Appropriations Act, 2012 (through 10/4/11)
Public Law 112-36, Continuing Appropriations Act, 2012 (through 11/18/11)
Public Law 112-67, 4th FY2012 Continuing Resolution (through December 17, 2011)
Public Law 112-68, 5th FY2012 Continuing Resolution (through December 23, 2011)
Public Law 112-25, Budget Control Act of 2011
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2011
In Q3, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on Oct. 18, 2011.
Original Filing: 300416254.xml
Lobbying Issues
S.1599, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2012, provisions relating to NIH
H.R.2219, Department of Defense Appropriations, FY2012, Disease specific program
Monitor the following:
H.R.2017, Continuing Appropriations Act, FY2012
H.R.2608, Continuing Appropriations Act, FY2012
Public Law 112-25, Budget Control Act of 2011
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2011
In Q2, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on July 19, 2011.
Original Filing: 300394616.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2012, provisions relating to NIH
Department of Defense Appropriations, FY2012, Disease specific programPublic Law 112-8, Further Additional Continuing Appropriations Amendments, FY2011, provisions related to NIH.
Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY2011, provisions related to NIH.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2011
In Q1, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on April 19, 2011.
Original Filing: 300368793.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2012, provisions relating to NIH
Department of Defense Appropriations, FY2012, Disease specific programPublic Law 112-4, Further Continuing Appropriations Amendments, FY2011, provisions related to NIH
Public Law 112-6, Additional Continuing Appropriations Amendments, FY2011, provisions related to NIH
H.R.1/S.Amdt. 149, Full-Year Continuing Appropriations Act, FY2011, provisions related to NIH
Public Law 111-322, Continuing Appropriations and Surface Transportation Extensions Act, FY2011, provisions relating to NIH
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2010
In Q4, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on Jan. 18, 2011.
Original Filing: 300340132.xml
Lobbying Issues
S.3686, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2011, provisions relating to NIH
S.3800, Department of Defense Appropriations Act, FY2011, Disease specific program
Public Law 111-242, Continuing Appropriations Act, FY2011, Disease specific program and provisions relating to NIHPublic Law 111-290, Making further continuing appropriations for fiscal year 2011, and for other purposes, provisions relating to NIH
Public Law 111-317, Making further continuing appropriations for fiscal year 2011, and for other purposes, provisions relating to NIH
Public Law 111-322, Continuing Appropriations and Surface Transportation Extensions Act, FY2011, provisions relating to NIH
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2010
In Q3, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on Oct. 19, 2010.
Original Filing: 300317442.xml
Lobbying Issues
S.3686, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2011, provisions relating to NIH
S.3800, Department of Defense Appropriations Act, FY2011, Disease specific program
H.R.3081, Continuing Appropriations Act, FY2011, Disease specific program and provisions relating to NIH
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2010
In Q2, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on July 16, 2010.
Original Filing: 300288273.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2011, provisions relating to NIH
Department of Defense Appropriations Act, FY2011, Disease specific program
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2010
In Q1, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on April 19, 2010.
Original Filing: 300262347.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2011, provisions relating to NIH
Department of Defense Appropriations Act, FY2011, Disease specific program
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2009
In Q4, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on Jan. 18, 2010.
Original Filing: 300234101.xml
Lobbying Issues
H.R.3293, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2010, provisions relating to NIH
H.R.3326, Department of Defense Appropriations Act, FY2010, disease specific programH.R.2918, Legislative Branch Appropriations Act, FY2010, Division B Continuing Appropriations Resolution, provisions regarding NIH; and disease specific program
H.R.2996, Department of the Interior, Environment, and Related Agencies Appropriations Act, FY2010, Division B is the
Further Continuing Appropriations Resolution, FY2010, Provisions relating to NIH
H.R.3288, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, FY2010, the
Consolidated Appropriations Act, FY2010, Provisions relating to NIH
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2009
In Q3, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on Oct. 16, 2009.
Original Filing: 300206766.xml
Lobbying Issues
H.R.3293, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2010, provisions relating to NIH
H.R.3326, Department of Defense Appropriations Act, FY2010, disease specific programH.R.2918, Legislative Branch Appropriations Act, FY2010, Division B Continuing Appropriations Resolution, provisions regarding NIH; and disease specific program
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2009
In Q2, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on July 15, 2009.
Original Filing: 300177402.xml
Lobbying Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2010, provisions relating to NIH
Department of Defense Appropriations Act, FY2010, disease specific program
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2009
In Q1, Van Scoyoc Associates lobbied for Neurofibromatosis, Inc. Midwest , earning $10,000. The report was filed on April 12, 2009.
Original Filing: 300146319.xml
Lobbying Issues
H.R. 1105, Omnibus Appropriations Act, FY2009; provisions relating to NIH
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2010, provisions relating to NIH
Department of Defense Appropriations Act, FY2010, disease specific program
Agencies Lobbied
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...